The recognition of bacteria is mediated by host pattern recognition receptors (PRRs) that detect conserved microbial structures and activate immune responses against the pathogen. These PRRs include membrane-bound toll-like receptors (TLRs) and cytosolic nod-like receptors (NLRs). In response to bacterial recognition, TLRs and several NLRs induce transcriptional induction of inflammatory and antimicrobial genes as well as type I IFNs. In addition, a set of NLRs including NLRP1, NLRP3, and NLRC4 is responsible for triggering the activation of the inflammasome, a molecular platform that drives the activation of caspase-1, a protease responsible for the maturation and secretion of IL-1β and IL-18 (Franchi et al., [@B7]). A feature of the inflammasomes is the use of the adaptor ASC (apoptosis-related speck-like protein) to link NLRs to pro-caspase-1, a critical step in the activation of caspase-1.

*Legionella pneumophila* (*Legionella*) is a Gram-negative facultative intracellular bacterium which causes an acute form of pneumonia called Legionnaires' disease. After infection of macrophages, bacteria-containing phagosomes are converted into specialized *Legionella*-containing vacuoles (LCV) where the bacterium replicates. Interestingly, while human macrophages are permissive, most inbred mouse strains, with the exception of the A/J mouse strain, are non-permissive for intracellular proliferation of *L. pneumophila*. Previous studies revealed several PPRs that are involved in the detection of *Legionella*. Among them, TLR5, NLRC4, and Naip5, are activated though the recognition of flagellin, a major component of the flagellum. While TLR5 recognizes flagellin during the engulfment of *Legionella*, NLRC4 and Naip5 sense flagellin released into the cytosol. In mouse macrophages cytosolic flagellin promote the assembly of the NLRC4 inflammasome inducing the activation of caspase-1 and secretion of IL-1β and IL-18. Notably, NLRC4-dependent caspase-1 activation was found to restrict the intracellular growth of *Legionella*, at least in part, by promoting the fusion of the LCV with lysosomes (Amer et al., [@B4]). In mouse macrophages, the regulation of intracellular *Legionella* growth by the NLRC4 inflammasome is independent of IL-1β and IL-18, but relies on caspase-7, another protein substrate of caspase-1 (Akhter et al., [@B3]). In addition, Naip5 contributes to the recognition of the C-terminal portion of flagellin; however, Naip5 can restrict *Legionella* growth independently of the NLRC4 inflammasome because full length flagellin induces caspase-1 activation in the absence of Naip5 (Lightfield et al., [@B8]). In mouse macrophages, NLRC4 and Naip5 also restrict pathogen growth by the induction of macrophage cell death under conditions of high multiplicity of infection (Case et al., [@B6]).

The role of ASC in controlling *Legionella* replication has turned out to be complex. The adaptor ASC regulates not only caspase-1 activation, but also cell death and the transcription factor NF-κB by mechanisms that remain poorly understood. Recent work from Amer et al. ([@B4]) have provided insight into the role of ASC in the control of *Legionella* replication in human monocytes and mouse macrophages (Abdelaziz et al., [@B1],[@B2]). A main difference between human monocytes and mouse macrophages is that human monocytes, but not mouse macrophages from many strains including C57BL6, allow replication of *Legionella*. In an attempt to understand this differential response, Amer et al. ([@B4]) evaluated the inflammasome and found that unlike in non-permissive mouse macrophages, *Legionella* did not induce caspase-1 activation in human monocytes. The lack of caspase-1 activation could be explained by the ability of *Legionella* to inhibit the expression of NLRC4 and, to a lesser extent, ASC. To confirm that the down-regulation of ASC had a role in preventing caspase-1 activation, they transfected primary monocytes with a ASC-producing plasmid and found that the expression of ASC restored caspase-1 activation and restriction of *Legionella* replication. As *Legionella* does not induce caspase-1 activation in human monocytes, Amer et al. ([@B4]) also assessed whether ASC was involved in restricting *Legionella* replication independent of its role on caspase-1 and found that depletion of ASC by siRNA promoted activation of NF-κB and enhanced bacterial growth in human monocytes. In summary, this work reveals a mechanism by which *Legionella* evades recognition by the inflammasome and new function of ASC in restricting pathogen replication in human monocytes.

Amer et al. ([@B4]) also investigated the role of ASC in mouse macrophages where activation of the caspase-1/caspases-7 cascade restricts *Legionella* replication. It was found that while NLRC4-deficient macrophages failed to restrict bacterial growth, ASC-deficient macrophages were capable of doing so as well as wild-type macrophages. The authors provided evidence that ASC-deficient macrophages can still induce caspase-1 activation, albeit to a greatly reduced extent. Their results support the existence of a minor NLRC4-dependent, ASC-independent pathway of caspase-1 activation that is sufficient to promote the fusion of the LCV to the lysosomes leading to inhibition of bacterial replication. In this model, ASC amplifies, but it is not necessary, for caspase-1 activation in the context of *Legionella* infection. Alternatively, it is possible that two different protein complexes with different function might be formed, one containing NLRC4, ASC, and caspase-1 that is responsible for the secretion of IL-1β/IL-18 and the other formed by NLRC4 and caspase-1 that is responsible for restricting bacterial replication and/or inducing cell death (Broz et al., [@B5]; Figure [1](#F1){ref-type="fig"}A). As *Legionella* mutants lacking flagellin do not activate the NLRC4 inflammasome and replicate in wild-type mouse macrophages, the authors investigated whether ASC could restrict bacterial replication independent on its role in caspase-1 activation (Figure [1](#F1){ref-type="fig"}B). They found that *Legionella* mutant lacking flagellin replicated more effectively in ASC-deficient cells, and this correlated with reduced cell death. Lastly, the authors showed that ASC was also able to restrict bacterial replication in caspase-1-deficient cells and this was associated with reduced activation of NF-κB and macrophage survival (Figure [1](#F1){ref-type="fig"}B). These results suggest that ASC controls *Legionella* replication through the regulation of cell survival which is only revealed in caspase-1-deficient macrophages. A potential problem with the interpretation of these experiments is that in this setting the higher number of intracellular bacteria may secondarily result in enhanced NF-κB activation. More research is needed to better understand the link between ASC and NF-κB activation in controlling the permissiveness to *Legionella* replication.

![**(A)** Schematic representation of the proposed function of NLRC4, ASC, and caspase-1 in the regulation of *L. pneumophila* replication in macrophages. The NLRC4--ASC--caspase-1 inflammasome promotes the maturation of pro-IL-1β whereas NLRC4-caspase-1 promotes the fusion of *Legionella-*containing vacuoles (LCV) with lysosomes, leading to bacterial degradation. Note that in this model ASC is required for the maturation of IL-1β but is not necessary to promote LCV fusion with lysosomes. **(B)** Schematic representation of host proteins involved in restricting *Legionella* replication in non-permissive mouse macrophages and their proposed mode of action. See text for more details.](fmicb-02-00057-g001){#F1}

In summary, the recent work by Amer et al. ([@B4]) provide insight into the role of ASC in the activation of the NLRC4 inflammasome and reveal that ASC can restrict *Legionella* replication via different mechanisms including caspase-1 activation, the modulation of NF-κB and the induction of cell death.
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